Indices › NIFTY Pharma TRI
NIFTY Pharma TRI
Shown through Nippon India Nifty Pharma ETF - Direct Plan, the lowest-cost fund tracking this index, until the official NSE TRI file is imported. Figures run slightly below the index by the fund's costs.
Level
29.17
19 Nov 2026
1 year
+25.28%
3 years (CAGR)
+21.97%
5 years (CAGR)
+16.60%
10 years (CAGR)
—
Growth of ₹100 since 6 Jul 2021
Calendar years
Risk
Volatility i
14.96%
Sharpe i
1.03
Deepest fall i
−20.98%
Oct 2021 → Mar 2023
Below its high i
−1.80%
Worst 1-year i
−15.30%
Middle 1-year
+13.45%
1-year periods with a loss i
26%
5-year SIP XIRR i
+20.60%
Funds that track it
| Fund | 1Y | 3Y | Tracking error |
|---|---|---|---|
| Nippon India Nifty Pharma ETF Nippon India · Equity ETFs | +25.28% | +21.97% | 0.00% |
| ICICI Prudential Nifty Pharma Index Fund ICICI Pru · Index Funds (Equity) | +24.97% | +21.56% | 0.11% |
| ICICI Prudential Nifty Pharma Index Fund ICICI Pru · Index Funds (Equity) | +24.16% | +20.81% | 0.12% |
| ICICI Prudential Nifty Pharma ETF ICICI Pru · Equity ETFs | — | — | — |
Lower tracking error = closer copy of the index.